Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 52011XC1230(02)

    Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka nuo 2011 m. rugsėjis 1 d. iki 2011 m. spalis 31 d. (Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnį arba 38 straipsnį)

    OL C 383, 2011 12 30, p. 1–16 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    30.12.2011   

    LT

    Europos Sąjungos oficialusis leidinys

    C 383/1

    Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka nuo 2011 m. rugsėjis 1 d. iki 2011 m. spalis 31 d.

    (Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004  (1) 13 straipsnį arba 38 straipsnį)

    2011/C 383/01

    —   Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta

    Sprendimo data

    Vaisto pavadinimas

    INN (Tarptautinis nepatentuotas pavadinimas)

    Rinkodaros leidimo turėtojas

    Įrašo numeris Bendrijos vaistų registre

    Farmacinė forma

    ATC kodas (Anatominis terapinis cheminis kodas)

    Pranešimo data

    2.9.2011

    Vibativ

    telavancinas

    Astellas Pharma Europe B.V.

    Elisabethhof 19,

    NL-2353 EW Leiderdorp,

    Nederland

    EU/1/11/705/001-002

    Milteliai koncentratui infuziniam tirpalui

    J01XA03

    6.9.2011

    2.9.2011

    Votubia

    Everolimuzas

    Novartis Europharm Limited

    Wimblehurst Road, Horsham,

    West Sussex,

    RH12 5AB,

    United Kingdom

    EU/1/11/710/001-007

    Tabletės

    L01XE10

    6.9.2011

    5.9.2011

    Zytiga

    abirateronas

    Janssen-Cilag International NV

    Turnhoutseweg 30,

    B-2340 Beerse,

    België

    EU/1/11/714/001

    Tabletės

    L02BX03

    7.9.2011

    16.9.2011

    Dexdor

    deksmedetomidinas

    Orion Corporation

    Orionintie 1,

    FI-02200 Espoo,

    Suomi

    EU/1/11/718/001-006

    Koncentratas infuziniam tirpalui

    N05CM18

    21.9.2011

    19.9.2011

    Incivo

    telapreviro

    Janssen-Cilag International NV

    Turnhoutseweg 30,

    B-2340 Beerse,

    België

    EU/1/11/720/001

    Plėvele dengta tabletė

    Pending

    22.9.2011

    30.9.2011

    Pramipexole Accord

    pramipeksolis

    Accord Healthcare Limited

    5th Floor Charles House, 108/110 Finchley road,

    London

    NW3 5JJ,

    United Kingdom

    EU/1/11/728/001-010

    Tabletės

    N04BC05

    4.10.2011

    3.10.2011

    Levetiracetam Accord

    Levetiracetamas

    Accord Healthcare Limited

    5th Floor Charles House, 108/110 Finchley road,

    London

    NW3 5JJ,

    United Kingdom

    EU/1/11/712/001-028

    Plėvele dengta tabletė

    N03AX14

    5.1.2011

    3.10.2011

    Levetiracetam Actavis

    Levetiracetamas

    Actavis Group PTC ehf.

    Reykjavikurvegur 76-78,

    220 Hafnarfjordur,

    Iceland

    EU/1/11/713/001-040

    Plėvele dengta tabletė

    N03AX14

    5.10.2011

    3.10.2011

    Matever

    Levetiracetamas

    Pharmathen S.A.

    6 Dervenakion,

    15351 Pallini Attiki,

    Ελλάδα

    EU/1/11/711/001-030

    Koncentratas infuziniam tirpalui

    Plėvele dengta tabletė

    N03AX14

    6.10.2011

    3.10.2011

    Telmisartan Teva Pharma

    telmisartanas

    Teva Pharma B.V.

    Computerweg 10,

    3542 DR Utrecht,

    Nederland

    EU/1/11/719/001-060

    Tabletės

    C09CA07

    5.10.2011

    27.10.2011

    Eurartesim

    dihidroartemizininas / piperakvino tetrafosfatas

    Sigma-Tau Industrie Farmaceutiche Riunite S.p.A

    Viale Shakespeare 47,

    00144 Rome,

    Italia

    EU/1/11/716/001-005

    Plėvele dengta tabletė

    P01BF05

    2.11.2011


    —   Rinkodaros leidimo pakeitimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta

    Sprendimo data

    Vaisto pavadinimas

    Rinkodaros leidimo turėtojas

    Įrašo numeris Bendrijos vaistų registre

    Pranešimo data

    2.9.2011

    CoAprovel

    Sanofi Pharma Bristol-Myers Squibb SNC

    174 avenue de France -

    75013 Paris,

    France

    EU/1/98/086/001-034

    6.9.2011

    2.9.2011

    Lucentis

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham, West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/06/374/001

    6.9.2011

    2.9.2011

    Torisel

    Wyeth Europa Ltd

    Huntercombe Lane South, Taplow, Maidenhead,

    Berkshire

    SL6 0PH,

    United Kingdom

    EU/1/07/424/001

    6.9.2011

    5.9.2011

    Advagraf

    Astellas Pharma Europe B.V.

    Elisabethhof 19,

    NL-2353 EW Leiderdorp,

    Nederland

    EU/1/07/387/001-026

    7.9.2011

    5.9.2011

    Aflunov

    Novartis Vaccines and Diagnostics S.r.l.

    Via Fiorentina, 1,

    53100 Siena,

    Italia

    EU/1/10/658/001-002

    7.9.2011

    5.9.2011

    Apidra

    Sanofi-Aventis Deutschland GmbH

    D-65926 Frankfurt am Main,

    Deutschland

    EU/1/04/285/001-036

    7.9.2011

    5.9.2011

    Cayston

    Gilead Sciences International Limited

    Granta Park, Abington,

    Cambridge

    CB21 6GT,

    United Kingdom

    EU/1/09/543/001-002

    7.9.2011

    5.9.2011

    Insuman

    Sanofi-Aventis Deutschland GmbH

    D-65926 Frankfurt am Main,

    Deutschland

    EU/1/97/030/028-195

    7.9.2011

    5.9.2011

    ProQuad

    Sanofi Pasteur MSD, SNC

    8, rue Jonas Salk,

    69007 Lyon,

    France

    EU/1/05/323/001-013

    7.9.2011

    5.9.2011

    Removab

    Fresenius Biotech GmbH

    Am Haag 6-7,

    D-82166 Graefelfing,

    Deutschland

    EU/1/09/512/001-002

    7.9.2011

    5.9.2011

    Simponi

    Janssen Biologics B.V.

    Einsteinweg 101,

    CB Leiden 2333,

    Nederland

    EU/1/09/546/001-004

    7.9.2011

    5.9.2011

    Viracept

    Roche Registration Limited

    6 Falcon Way, Shire Park,

    Welwyn Garden City,

    AL7 1TW,

    United Kingdom

    EU/1/97/054/001

    EU/1/97/054/004-005

    7.9.2011

    7.9.2011

    CANCIDAS

    Merck Sharp & Dohme Ltd

    Hertford Road, Hoddesdon,

    Hertfordshire

    EN11 9BU,

    United Kingdom

    EU/1/01/196/001

    EU/1/01/196/003

    9.9.2011

    7.9.2011

    Circadin

    RAD Neurim Pharmaceuticals EEC Limited

    One Forbury Square, The Forbury, Reading,

    Berkshire

    RG1 3EB,

    United Kingdom

    EU/1/07/392/003

    13.9.2011

    7.9.2011

    Irbesartan HCT Winthrop

    Sanofi-Aventis

    174, avenue de France,

    F-75013 Paris,

    France

    EU/1/06/377/001-028

    9.9.2011

    13.9.2011

    Ammonaps

    Swedish Orphan Biovitrum International AB

    SE-11276 Stockholm,

    Sverige

    EU/1/99/120/003-004

    15.9.2011

    13.9.2011

    Luminity

    Lantheus MI UK Limited

    Festival House - 39 Oxford Street - Newbury -

    Berkshire

    RG14 1JG -

    United Kingdom

    EU/1/06/361/001-002

    15.9.2011

    13.9.2011

    Raloxifene Teva

    Teva Pharma B.V.

    Computerweg 10,

    3542 DR Utrecht,

    Nederland

    EU/1/10/627/001-003

    15.9.2011

    13.9.2011

    Synagis

    Abbott Laboratories Ltd

    Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead,

    Berkshire

    SL6 4XE,

    United Kingdom

    EU/1/99/117/001-002

    15.9.2011

    13.9.2011

    Xelevia

    Merck Sharp & Dohme Ltd

    Hertford Road, Hoddesdon,

    Hertfordshire

    EN11 9BU,

    United Kingdom

    EU/1/07/382/001-018

    15.9.2011

    13.9.2011

    Zypadhera

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    NL-3991 RA Houten,

    Nederland

    EU/1/08/479/001-003

    16.9.2011

    16.9.2011

    Aerius

    Schering Plough Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/00/160/001-013

    EU/1/00/160/022-034

    EU/1/00/160/036-069

    21.9.2011

    16.9.2011

    Angiox

    The Medicines Company UK Ltd

    115 L Milton Park, Abingdon,

    Oxfordshire,

    OX14 4SA,

    United Kingdom

    EU/1/04/289/001

    20.9.2011

    16.9.2011

    Azomyr

    Schering Plough Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/00/157/001-013

    EU/1/00/157/022-067

    21.9.2011

    16.9.2011

    Azopt

    Alcon Laboratories (UK) Ltd.

    Pentagon Park, Boundary Way, Hemel Hempstead,

    Herts

    HP2 7UD,

    United Kingdom

    EU/1/00/129/001-003

    20.9.2011

    16.9.2011

    Ilaris

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/09/564/001-003

    20.9.2011

    16.9.2011

    Myclausen

    Herbert J. Passauer GmbH & Co. KG

    Stubenrauchstrasse 33,

    14167 Berlin,

    Deutschland

    EU/1/10/647/001-004

    20.9.2011

    16.9.2011

    Neoclarityn

    Schering Plough Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/00/161/001-013

    EU/1/00/161/022-067

    21.9.2011

    16.9.2011

    NeuroBloc

    Eisai Limited

    European Knowledge Centre, Mosquito Way, Hatfield,

    Hertfordshire,

    AL10 9SN,

    United Kingdom

    EU/1/00/166/001-003

    20.9.2011

    16.9.2011

    Pandemrix

    GlaxoSmithKline Biologicals S.A.

    rue de l'Institut 89,

    Rixensart, B-1330

    Belgique

    EU/1/08/452/001

    21.9.2011

    16.9.2011

    Resolor

    Shire-Movetis NV

    Veedjik 58 (1004),

    B-2300 Turnhout,

    Belgium

    EU/1/09/581/001-008

    21.9.2011

    16.9.2011

    Suboxone

    RB Pharmaceuticals Limited

    103-105 Bath Road, Slough,

    Berkshire,

    SL1 3UH,

    United Kingdom

    EU/1/06/359/001-004

    20.9.2011

    16.9.2011

    Viramune

    Boehringer Ingelheim International GmbH

    Binger Strasse 173-

    D - 55216 Ingelheim am Rhein,

    Deutschland

    EU/1/97/055/001-009

    26.9.2011

    19.9.2011

    Byetta

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    3991 RA Houten,

    Nederland

    EU/1/06/362/001-004

    22.9.2011

    19.9.2011

    Docetaxel Winthrop

    Aventis Pharma S.A.

    20 avenue Raymond Aron,

    F-92165 Antony Cedex,

    France

    EU/1/07/384/001-005

    22.9.2011

    19.9.2011

    Ifirmasta

    KRKA, d.d., Novo mesto

    Šmarješka cesta 6,

    8501 Novo mesto,

    Slovenija

    EU/1/08/480/001-018

    22.9.2011

    19.9.2011

    Temomedac

    medac Gesellschaft für klinische Spezialpräparate mbH

    Fehlandtstrasse 3,

    D-20354 Hamburg –

    Deutschland

    EU/1/09/605/001-012

    22.9.2011

    19.9.2011

    Zonegran

    Eisai Limited

    European Knowledge Centre, Mosquito Way, Hatfield,

    Hertfordshire,

    AL10 9SN,

    United Kingdom

    EU/1/04/307/001-021

    22.9.2011

    22.9.2011

    Clopidogrel DURA

    Mylan dura GmbH

    Wittichstraße 6,

    D-64295 Darmstadt,

    Deutschland

    EU/1/09/560/001-009

    26.9.2011

    22.9.2011

    Ixiaro

    Intercell AG

    Campus Vienna Biocenter 3

    A-1030 Wien,

    Österreich

    EU/1/08/501/001-002

    26.9.2011

    22.9.2011

    Leflunomide ratiopharm

    ratiopharm GmbH

    Graf-Arco-Straße 3,

    D-89079 Ulm,

    Deutschland

    EU/1/10/654/001-004

    26.9.2011

    22.9.2011

    Pergoveris

    Merck Serono Europe Limited

    56, Marsh Wall,

    London

    E14 9TP,

    United Kingdom

    EU/1/07/396/001-003

    26.9.2011

    22.9.2011

    RoActemra

    Roche Registration Limited

    6 Falcon Way, Shire Park,

    Welwyn Garden City,

    AL7 1TW,

    United Kingdom

    EU/1/08/492/001-006

    26.9.2011

    22.9.2011

    Taxotere

    Aventis Pharma S.A.

    20 avenue Raymond Aron,

    F-92165 Antony Cedex,

    France

    EU/1/95/002/001-005

    27.9.2011

    30.9.2011

    Aerinaze

    SP Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/07/399/001-006

    4.10.2011

    3.10.2011

    Elaprase

    Shire Human Genetic Therapies AB

    Svärdvägen 11D,

    18233 Danderyd,

    Sverige

    EU/1/06/365/001-003

    5.10.2011

    3.10.2011

    Lysodren

    Laboratoire HRA Pharma

    15, rue Béranger,

    75003 Paris,

    France

    EU/1/04/273/001

    5.10.2011

    3.10.2011

    Sprycel

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road,

    Uxbridge

    UB8 1DH,

    United Kingdom

    EU/1/06/363/001-015

    5.10.2011

    3.10.2011

    Xagrid

    Shire Pharmaceutical Contracts Ltd

    Hampshire International Business Park, Chineham, Basingstoke,

    Hampshire

    RG24 8EP,

    United Kingdom

    EU/1/04/295/001

    5.10.2011

    6.10.2011

    NeoRecormon

    Roche Registration Limited

    6 Falcon Way, Shire Park,

    Welwyn Garden City,

    AL7 1TW,

    United Kingdom

    EU/1/97/031/001-046

    10.10.2011

    6.10.2011

    Noxafil

    SP Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/05/320/001

    10.10.2011

    6.10.2011

    Sildenafil Actavis

    Actavis Group PTC ehf.

    Reykjavikurvegur 76-78,

    220 Hafnarfjordur,

    Iceland

    EU/1/09/595/001-015

    10.10.2011

    6.10.2011

    Sustiva

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road,

    Uxbridge

    UB8 1DH,

    United Kingdom

    EU/1/99/110/001-005

    EU/1/99/110/008-010

    10.10.2011

    6.10.2011

    Topotecan Hospira

    Hospira UK Limited

    Queensway, Royal Leamington Spa,

    Warwickshire

    CV31 3RW,

    United Kingdom

    EU/1/10/633/001-002

    10.10.2011

    12.10.2011

    Celsentri

    ViiV Healthcare UK Ltd

    980 Great West Road, Brentford,

    Middlesex,

    TW8 9GS,

    United Kingdom

    EU/1/07/418/001-010

    13.10.2011

    12.10.2011

    Galvus

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/07/414/001-010

    EU/1/07/414/018

    14.10.2011

    12.10.2011

    Invega

    Janssen-Cilag International NV

    Turnhoutseweg, 30 -

    2340 Beerse –

    België

    EU/1/07/395/001-095

    14.10.2011

    12.10.2011

    Jalra

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/08/485/001-011

    14.10.2011

    12.10.2011

    Rilonacept Regeneron

    Regeneron UK Limited

    40 Bank Street,

    London,

    E14 5DS

    United Kingdom

    EU/1/09/582/001

    14.10.2011

    12.10.2011

    Stelara

    Janssen-Cilag International NV

    Turnhoutseweg, 30 -

    2340 Beerse –

    België

    EU/1/08/494/001-004

    14.10.2011

    12.10.2011

    Teysuno

    Taiho Pharma Europe, Limited

    55 Colmore Row, Birmingham,

    West Midlands,

    B3 2AS,

    United Kingdom

    EU/1/11/669/001-004

    14.1.2011

    12.10.2011

    Xeplion

    Janssen-Cilag International NV

    Turnhoutseweg 30,

    B-2340 Beerse,

    België

    EU/1/11/672/001-006

    14.10.2011

    12.10.2011

    Xiliarx

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/08/486/001-011

    14.10.2011

    17.10.2011

    Docetaxel Teva

    Teva Pharma B.V.

    Computerweg 10,

    3542 DR Utrecht,

    Nederland

    EU/1/09/611/001-002

    19.10.2011

    20.10.2011

    Arixtra

    Glaxo Group Ltd.

    Greenford Road, Greenford,

    Middlesex

    UB6 0NN,

    United Kingdom

    EU/1/02/206/001-035

    24.10.2011

    20.10.2011

    Karvezide

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road,

    Uxbridge

    UB8 1DH,

    United Kingdom

    EU/1/98/085/001-034

    24.10.2011

    20.10.2011

    Mircera

    Roche Registration Limited

    6 Falcon Way, Shire Park,

    Welwyn Garden City,

    AL7 1TW,

    United Kingdom

    EU/1/07/400/008-013

    EU/1/07/400/017-024

    24.10.2011

    20.10.2011

    Naglazyme

    BioMarin Europe Ltd

    164 Shaftesbury Avenue,

    London

    WC2H 8HL,

    United Kingdom

    EU/1/05/324/001-002

    24.10.2011

    20.10.2011

    Zypadhera

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    NL-3991 RA Houten,

    Nederland

    EU/1/08/479/001-003

    24.10.2011

    20.10.2011

    Zyprexa

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    3991 RA Houten,

    Nederland

    EU/1/96/022/002

    EU/1/96/022/004

    EU/1/96/022/006

    EU/1/96/022/009-012

    EU/1/96/022/014

    EU/1/96/022/016-017

    EU/1/96/022/019-040

    28.9.2011

    20.10.2011

    Zyprexa Velotab

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    3991 RA Houten,

    Nederland

    EU/1/99/125/001-020

    28.9.2011

    24.10.2011

    Alimta

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    3991 RA Houten,

    Nederland

    EU/1/04/290/001-002

    26.10.2011

    24.10.2011

    Avonex

    Biogen Idec Ltd

    Innovation House,

    70 Norden Road, Maidenhead,

    Berkshire

    SL6 4AY,

    United Kingdom

    EU/1/97/033/002-006

    26.10.2011

    24.10.2011

    CoAprovel

    Sanofi Pharma Bristol-Myers Squibb SNC

    174 avenue de France -

    75013 Paris,

    France

    EU/1/98/086/001-034

    26.10.2011

    24.10.2011

    Daxas

    Nycomed GmbH

    Byk-Gulden-Str. 2,

    D-78467 Konstanz,

    Deutschland

    EU/1/10/636/001-007

    26.10.2011

    24.10.2011

    Docetaxel Winthrop

    Aventis Pharma S.A.

    20 avenue Raymond Aron,

    F-92165 Antony Cedex,

    France

    EU/1/07/384/001-005

    26.10.2011

    24.10.2011

    Ebixa

    H. Lundbeck A/S

    Ottiliavej 9,

    DK-2500 Valby,

    Danmark

    EU/1/02/219/001-049

    26.10.2011

    24.10.2011

    Efient

    Eli Lilly Nederland B.V.

    Grootslag 1-5,

    3991 RA Houten,

    Nederland

    EU/1/08/503/001-016

    26.10.2011

    24.10.2011

    Emend

    Merck Sharp & Dohme Ltd

    Hertford Road, Hoddesdon,

    Hertfordshire

    EN11 9BU,

    United Kingdom

    EU/1/03/262/001-008

    27.10.2011

    24.10.2011

    Erbitux

    Merck KGaA

    Frankfurter Straße 250,

    64271 Darmstadt,

    Deutschland

    EU/1/04/281/001-005

    26.10.2011

    24.10.2011

    Humira

    Abbott Laboratories Ltd

    Abbott House, Vanwall Business Park,

    Vanwall Road, Maidenhead,

    Berkshire

    SL6 4XE,

    United Kingdom

    EU/1/03/256/001-010

    26.10.2011

    24.10.2011

    Icandra

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/08/484/001-018

    26.10.2011

    24.10.2011

    IntronA

    Schering Plough Europe

    Rue de Stalle, 73,

    1180 Bruxelles,

    Belgique -

    Stallestraat, 73 -

    1180 Brussel,

    België

    EU/1/99/127/011-039

    EU/1/99/127/041-044

    27.10.2011

    24.10.2011

    Irbesartan HCT Winthrop

    Sanofi-Aventis

    174, avenue de France,

    F-75013 Paris,

    France

    EU/1/06/377/001-028

    26.10.2011

    24.10.2011

    Keppra

    UCB Pharma SA.

    Allée de la Recherche 60,

    1070 Bruxelles,

    Belgique/

    Researchdreef, 60,

    Brussel 1070,

    België

    EU/1/00/146/001-032

    26.10.2011

    24.10.2011

    Kivexa

    ViiV Healthcare UK Ltd

    980 Great West Road, Brentford,

    Middlesex,

    TW8 9GS,

    United Kingdom

    EU/1/04/298/001-003

    26.10.2011

    24.10.2011

    Levemir

    Novo Nordisk A/S

    Novo Allé,

    DK-2880 Bagsvaerd,

    Danmark

    EU/1/04/278/001-016

    26.10.2011

    24.10.2011

    Lyrica

    Pfizer Ltd

    Ramsgate Road,

    Sandwich,

    Kent

    CT 139NJ,

    United Kingdom

    EU/1/04/279/001-044

    26.10.2011

    24.10.2011

    Nexavar

    Bayer Pharma AG

    Berlin 13342,

    Deutschland

    EU/1/06/342/001

    26.10.2011

    24.10.2011

    Onglyza

    Bristol Myers Squibb/AstraZeneca EEIG

    Bristol Myers Squibb House,

    Uxbridge Business Park,

    Sanderson Road, Uxbridge,

    Middlesex

    UB8 1DH,

    United Kingdom

    EU/1/09/545/001-015

    26.10.2011

    24.10.2011

    Prevenar 13

    Wyeth-Lederle Vaccines S.A.

    Pleinlaan 17 Boulevard de la Plaine,

    1050 Brussels - Bruxelles,

    Belgïe-Belgique

    EU/1/09/590/001-006

    26.10.2011

    24.10.2011

    Revatio

    Pfizer Limited

    Sandwich,

    Kent,

    CT13 9NJ,

    United Kingdom

    EU/1/05/318/001

    26.10.2011

    24.10.2011

    Rotarix

    GlaxoSmithKline Biologicals S.A.

    rue de l'Institut 89,

    Rixensart,

    B-1330

    Belgique

    EU/1/05/330/001-011

    26.10.2011

    24.10.2011

    Starlix

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/01/174/001-021

    26.10.2011

    24.10.2011

    Sycrest

    N.V. Organon

    Kloosterstraat 6,

    5349 AB Oss,

    Nederland

    EU/1/10/640/001-006

    26.10.2011

    24.10.2011

    Toviaz

    Pfizer Limited

    Ramsgate Road,

    Sandwich,

    Kent

    CT13 9NJ,

    United Kingdom

    EU/1/07/386/001-018

    26.10.2011

    24.10.2011

    Votrient

    Glaxo Group Limited

    Berkeley Avenue, Greenford,

    Middlesex

    UB6 0NN,

    United Kingdom

    EU/1/10/628/001-004

    26.10.2011

    24.10.2011

    Ziagen

    ViiV Healthcare UK Ltd

    980 Great West Road, Brentford,

    Middlesex,

    TW8 9GS,

    United Kingdom

    EU/1/99/112/001-002

    26.10.2011

    27.10.2011

    Advagraf

    Astellas Pharma Europe B.V.

    Elisabethhof 19,

    NL-2353 EW Leiderdorp,

    Nederland

    EU/1/07/387/001-026

    4.11.2011

    27.10.2011

    Axura

    Merz Pharmaceuticals GmbH

    Eckenheimer Landstr. 100,

    D-60318 Frankfurt/Main –

    Deutschland

    EU/1/02/218/001-003

    EU/1/02/218/005-030

    4.11.2011

    27.10.2011

    Ceprotin

    Baxter AG

    Industriestraße 67,

    A - 1221 Wien,

    Österreich

    EU/1/01/190/001-002

    4.11.2011

    27.10.2011

    Eucreas

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/07/425/001-018

    4.11.2011

    27.10.2011

    Exalief

    BIAL - Portela & Ca, SA

    A Av. da Siderurgia Nacional

    4745-457 S. Mamede do Coronado –

    Portugal

    EU/1/09/520/001-020

    4.11.2011

    27.10.2011

    Galvus

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/07/414/001-010

    EU/1/07/414/018

    4.11.2011

    27.10.2011

    Jalra

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/08/485/001-011

    4.11.2011

    27.10.2011

    Leflunomide Winthrop

    Sanofi-Aventis Deutschland GmbH

    D-65926 Frankfurt am Main,

    Deutschland

    EU/1/09/604/001-010

    1.11.2011

    27.10.2011

    Mixtard

    Novo Nordisk A/S

    Novo Allé,

    DK-2880 Bagsvaerd,

    Danmark

    EU/1/02/231/030-032

    1.11.2011

    27.10.2011

    Rapiscan

    Rapidscan Pharma Solutions EU Ltd.

    Regent's Place, 338 Euston Road,

    London

    NW1 3BT,

    UK

    EU/1/10/643/001

    4.11.2011

    27.10.2011

    Rasilamlo

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex,

    RH12 5AB,

    United Kingdom

    EU/1/11/686/001-056

    4.11.2011

    27.10.2011

    Riprazo

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/07/409/001-040

    1.11.2011

    27.10.2011

    Riprazo HCT

    Novartis Europharm Limited

    Wimblehurst Road, Horsham,

    West Sussex,

    RH12 5AB,

    United Kingdom

    EU/1/11/680/001-080

    4.11.2011

    27.10.2011

    Sprimeo

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/07/407/001-040

    1.11.2011

    27.10.2011

    Sprimeo HCT

    Novartis Europharm Limited

    Wimblehurst Road, Horsham,

    West Sussex,

    RH12 5AB,

    United Kingdom

    EU/1/11/683/001-080

    4.11.2011

    27.10.2011

    Taxotere

    Aventis Pharma S.A.

    20 avenue Raymond Aron,

    F-92165 Antony Cedex,

    France

    EU/1/95/002/001-005

    4.11.2011

    27.10.2011

    Tygacil

    Wyeth Europa Ltd.

    Huntercombe Lane South, Taplow, Maidenhead,

    Berkshire,

    SL6 0PH,

    United Kingdom

    EU/1/06/336/001

    4.11.2011

    27.10.2011

    Xiliarx

    Novartis Europharm Ltd

    Wimblehurst Road, Horsham,

    West Sussex

    RH12 5AB,

    United Kingdom

    EU/1/08/486/001-011

    4.11.2011


    —   Rinkodaros leidimo atšaukimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis)

    Sprendimo data

    Vaisto pavadinimas

    Rinkodaros leidimo turėtojas

    Įrašo numeris Bendrijos vaistų registre

    Pranešimo data

    3.10.2011

    Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals

    GlaxoSmithKline Biologicals S.A.

    Rue de l'Institut 89,

    1330 Rixensart,

    Belgique

    EU/1/08/478/001

    5.10.2011

    17.10.2011

    Ablavar

    TMC Pharma Services Ltd.

    Lodge Farm Barn, Elvetham Park Estate,

    Fleet Road, Hartley Wintney,

    Hampshire,

    RG27 8AS,

    United Kingdom

    EU/1/05/313/001-009

    19.10.2011


    —   Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004  (2) 38 straipsnis): Priimta

    Sprendimo data

    Vaisto pavadinimas

    INN (Tarptautinis nepatentuotas pavadinimas)

    Rinkodaros leidimo turėtojas

    Įrašo numeris Bendrijos vaistų registre

    Farmacinė forma

    ATC kodas (Anatominis terapinis cheminis kodas)

    Pranešimo data

    7.9.2011

    Nobivac Myxo-RHD

    gyvo 009 padermės miksomos viruso su HTL viruso vektoriumi

    Intervet International B.V.

    Wim de Körverstraat 35,

    5831 AN Boxmeer,

    Nederland

    EU/2/11/132/001-004

    Liofilizatas ir tirpiklis injekcinei suspensijai ruošti

    QI08AD

    9.9.2011

    13.9.2011

    Recocam

    meloksikamo

    CF Pharma Limited

    Unit 622, Northern Extension,

    Waterford,

    Ireland

    EU/2/11/133/001-003

    Injekcinis tirpalas

    QM01AC06

    15.9.2011

    6.10.2011

    Recuvyra

    Fentanilis

    Nexcyon Pharmaceuticals Ltd.

    Bank Barn, How Mill,

    Brampton,

    Cumbria

    CA8 9JY,

    UNITED KINGDOM

    EU/2/11/127/001

    Transderminis tirpalas

    QN02AB03

    11.10.2011


    —   Rinkodaros leidimo pakeitimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 38 straipsnis): Priimta

    Sprendimo data

    Vaisto pavadinimas

    Rinkodaros leidimo turėtojas

    Įrašo numeris Bendrijos vaistų registre

    Pranešimo data

    5.9.2011

    Improvac

    Pfizer Limited

    Ramsgate Road,

    Sandwich,

    Kent

    CT13 9NJ,

    United Kingdom

    EU/2/09/095/001-006

    7.9.2011

    13.9.2011

    Cortavance

    VIRBAC S.A.

    1ère Avenue 2065 m L.I.D. -

    06516 Carros –

    France

    EU/2/06/069/001

    15.9.2011

    16.9.2011

    Loxicom

    Norbrook Laboratories Limited

    Station Works, Newry,

    Co. Down,

    BT35 6JP,

    United Kindgom

    EU/2/08/090/001-026

    20.9.2011

    16.9.2011

    Porcilis Pesti

    Intervet International B.V.

    Wim de Körverstraat 35,

    5831 AN Boxmeer,

    Nederland

    EU/2/99/016/001-006

    21.9.2011

    19.9.2011

    ZULVAC 1 + 8 Ovis

    Pfizer Limited

    Ramsgate Road, Sandwich,

    Kent

    CT13 9NJ,

    United Kingdom

    EU/2/11/120/001-003

    22.9.2011

    20.10.2011

    Suprelorin

    VIRBAC S.A.

    1ère Avenue 2065 m L.I.D. -

    06516 Carros –

    France

    EU/2/07/072/003-004

    24.10.2011

    24.10.2011

    Meloxoral

    Le Vet B.V.

    Wilgenweg 7,

    3421 TV

    Oudewater,

    Nederland

    EU/2/10/111/001-007

    26.10.2011

    Norintieji susipažinti su nagrinėjamųjų vaistų vieša vertinimo ataskaita ir su ja susijusiais sprendimais, gali kreiptis į:

    The European Medicines Agency

    7, Westferry Circus,

    Canary Wharf

    UK - LONDON E14 4H

    (1)  OL L 136, 2004 4 30, p. 1.

    (2)  OL L 136, 2004 4 30, p. 1.

    Top